Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
529 News Items found
SKI immunologist Andrea Schietinger
Discovery of a Stem-like T Cell in Type 1 Diabetes Holds Potential for Improving Cancer Immunotherapy, Sloan Kettering Institute Scientists Say

As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.
In the Lab
Maria Jasin
Sloan Kettering Institute Researchers Discover One Way Genetic Mutations Occur During Formation of Eggs and Sperm

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.
Memorial Sloan Kettering Cancer Center research technician Matthew Solowsky
From Navy Veteran to MSK Cancer Researcher: Matthew Solowsky’s Story

Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center.
Finding
Yonina Murciano-Goroff, Jenny Xue, Bob Li, Piro Lito, and Yulei Zhao.
MSK Researchers Are Learning Why Some Patients Develop Resistance to Targeted Lung Cancer Drug

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.
Paul Marks Prize 2021 winners
Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs

By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Charles Rudin and Dana Pe'er
Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive

Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.
Justin Perry, PhD
Sloan Kettering Institute’s Justin Perry Honored with Distinguished NIH Director’s New Innovator Award

Justin Perry, PhD, cell biologist and immunologist of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named a recipient of the 2021 National Institutes of Health (NIH) Director’s New Innovator Award.
Katharine Hsu and Rosa Sottile
Unusual Immune Cell Type Could Be Good Target for Immunotherapy

Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Dana Pe'er, PhD
Sloan Kettering Institute’s Dana Pe’er Named Howard Hughes Medical Institute Investigator

Dana Pe’er, PhD, computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today.